Skip to main content
. 2017 Mar 21;8(26):42428–42437. doi: 10.18632/oncotarget.16403

Table 4. Individual characteristics of patients with MET exon 14 splice site mutations.

Patient cDNA MET position* Chr7 startposition** Chr7 endposition** Age (Years) Gender Ethnicity Smoking history Histology Othermutations
#1 c3082g>a; 116771987 116771987 75 Male Caucasian Current SC Spindle and giant cell carcinoma EGFR G719A
#2 exon 14 +2 t>g 116771989 116771989 65 Female Caucasian Current SC Pleomorphic carcinoma (ADK and Spindle cell carcinoma) -
#9 exon 14 -55_-54insCT 116771796 116771797 66 Female Arab Current SC Giant cell carcinoma -
#10 exon 14 -47c>t 116771802 116771802 68 Female Caucasian Ex-smoker SC Giant cell carcinoma KRAS G12C
#3 c3082g>a; 116771987 116771987 84 Female Never smoker ADC -
#4 c3082g>t; 116771987 116771987 64 Female Ex-smoker ADC -
#5 exon 14 -39_2947del45pb 116771810 116771854 79 Male African Never smoker ADC -
#6 exon 14 -16_2972del47pb 116771833 116771879 81 Female Never smoker ADC -
#7 exon 14 -39_-6del34pb 116771810 116771843 60 Female Never smoker ADC -
#8 c3082g>a; 116771987 116771987 63 Male Current ADC -
#11 exon 14 -55_-54insCT 116771796 116771797 39 Male Current ADC -
#12 exon 14 -55_-54insCT 116771796 116771797 77 Male African Current ADC -

SC: sarcomatoid carcinoma; ADC: adenocarcinoma

*cDNA according to COSMIC nomenclature

** gDNA according to www.genome.ucsc.edu (Dec2013) nomenclature